So not only are we assisting Janssen to enhance their data from a completed trial samples, they are assisting PIQ in validation of predicting cardiovascular disease in diabetics. This is an important trial for Janssen as from memory they were assessing to reduce CVD & applying for an extra indication for the drug from the FDA, which it looks like was successful:
Reading this just gave me goosebumps! GLTA
https://**promotion blocked**.com.au/proteomics-collaborate-agreement-us-pharma-giant-promarkerd/
- Forums
- ASX - By Stock
- PIQ
- Ann: Proteomics signs PromarkerD agreement with US big pharma
PIQ
proteomics international laboratories ltd
Add to My Watchlist
2.70%
!
38.0¢

Ann: Proteomics signs PromarkerD agreement with US big pharma, page-26
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $62.19M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 36.0¢ | $53.71K | 143.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 491 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 39195 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 491 | 0.380 |
1 | 49584 | 0.375 |
1 | 8000 | 0.370 |
1 | 20000 | 0.365 |
2 | 10616 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 39195 | 2 |
0.400 | 14573 | 2 |
0.410 | 100000 | 1 |
0.420 | 10000 | 1 |
0.425 | 2775 | 1 |
Last trade - 15.55pm 07/08/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |